News

Unilever (NYSE: UL) appears to be on sale. The British consumer goods giant currently offers investors a historically high yield of 4.2%, a level last seen during the 2007-2009 recession.Now, there

It's easy to see why investors might be wondering whether it's too late to buy shares of Novavax (NASDAQ: NVAX). After all, the vaccine manufacturer's Nuvaxovid jab is already cleared for sale in

Shares of Tesla (NASDAQ: TSLA) were spiking this morning after the electric vehicle (EV) maker reported strong second-quarter results. While revenue was below Wall Street's expectations, the

Image source: The Motley Fool.

Elevance Health Inc. (NYSE: ELV)Q2 2022 Earnings CallJul 20, 2022, 8:30 a.m. ET

Operator

Continue reading

Source Fool.com

Here's a surprising trend. Older viewers have recently become the primary source of growth in video streaming. Increasing numbers of people 50 and older have been cutting the cord on cable and

Shares of the fintech company Pagaya Technologies (NASDAQ: PGY) traded more than 16% lower as of 10:34 a.m. ET today after surging more than 100% at one point yesterday for no obvious reason.

Pagaya

Now is a great time for long-term investors to load up on some quality growth stocks. Although the bear market may be a frightening time to buy shares, there are many quality businesses that are

Coca-Cola (NYSE: KO) has a few big questions to answer for investors in late July. The beverage titan's stock has outperformed the market in 2022 thanks to perceptions that its business will be

A triple on a stock is quite the return. On average, the S&P 500 returns about 10.5% annually. At that rate, the S&P 500 would triple in 11 years from today's price. However, I wouldn't be surprised

Netflix (NASDAQ: NFLX) pleasantly surprised shareholders when it reported better-than-expected subscriber figures after the markets closed on Tuesday. Nevertheless, the streaming pioneer has

Gene-editing specialist Editas Medicine (NASDAQ: EDIT) has had a challenging 2022, even compared to the struggling stock market. The company's shares are down 35% this year and nearly 60% over the

As investors scramble to insulate their portfolios from the chaotic global economy, inflation, and a falling market, biotech stocks might seem a safe harbor. After all, these companies don't need to

Cryptocurrencies took a breather this morning after a nice rally in recent days, as investors digest more macro news and as the electric car maker Tesla (NASDAQ: TSLA) announced that it had sold

With Ethereum (CRYPTO: ETH) rallying these days, maybe it's a good time to revisit the "flippening." The term (and it's as fun to say out loud as it is to read or write) is the moment that Ethereum

Ethereum (CRYPTO: ETH), or rather, the Ethereum ecosystem's Ether token, is the second-largest cryptocurrency on the market. Ether prices soared all the way to $4,892 in November 2021, but have come

Proto Labs (NYSE: PRLB), a leading quick-turn contract manufacturer, is slated to report its second-quarter 2022 results before the market open on Friday, Aug. 5. An analyst conference call is

Swiss pharmaceutical giant Novartis (NYSE: NVS) prides itself on the breadth and depth of its oncology portfolio. Despite this, the company has failed to offer a drug in a specific class of

Amazon (NASDAQ: AMZN) is set to add another piece to its rapidly growing healthcare unit. Specifically, the e-commerce giant has reportedly offered to buy membership-based primary care provider

If your portfolio is teetering amid a turbulent bear market -- as pretty much everyone's is at the moment -- you need a plan to come out ahead, and you need to act on it. Fruitful investments made